Press Releases
Keyword Search
| Date | Title | ||
|---|---|---|---|
|
05/19/20
|
Summary ToggleT2 Biosystems’ Bacteria Panel Wins “Best New Technology Solution - Diagnostics" Award in MedTech Breakthrough Awards |
|
Achievement Underscores the Clinical Value of Company’s Rapid Diagnostic Test for Sepsis-causing Bacterial Pathogens in Bloodstream LEXINGTON, Mass. , May 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it |
|
05/05/20
|
Summary ToggleT2 Biosystems Announces First Quarter 2020 Financial Results |
|
LEXINGTON, Mass. , May 05, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the first quarter ended March 31, 2020 . Recent Highlights Achieved first quarter total revenue of $2.5 million |
|
04/21/20
|
Summary ToggleT2 Biosystems to Report First Quarter 2020 Financial Results on May 5, 2020 |
|
LEXINGTON, Mass. , April 21, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the first quarter of 2020 after market close on Tuesday, May 5, 2020. |
|
04/15/20
|
Summary ToggleT2 Biosystems Reports Granting of Inducement Award |
|
LEXINGTON, Mass. , April 15, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to four new employees. The awards were made on March 18, 2020 and April 14, 2020 under T2 Biosystems’ |
|
03/24/20
|
Summary ToggleT2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health’s Center for Discovery and Innovation |
|
New COVID-19 assay will be adapted to run on T2 Biosystems’ FDA-cleared T2Dx® Instrument LEXINGTON, Mass. , March 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it has entered into a worldwide |
|
03/24/20
|
Summary ToggleT2 Biosystems Announces Preliminary First Quarter 2020 Financial Results |
|
Suspends 2020 Financial Guidance LEXINGTON, Mass. , March 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited, preliminary financial result estimates for the quarter ended March 31, 2020 , and |
|
03/19/20
|
Summary ToggleT2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient, Inc. |
|
Contract recognizes products that bring improvements to the health care industry LEXINGTON, Mass. , March 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it was awarded an Innovative Technology |
|
02/24/20
|
Summary ToggleT2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results |
|
LEXINGTON, Mass. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2019 . Fourth Quarter and Recent Business and Financial |
|
02/12/20
|
Summary ToggleT2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020 |
|
LEXINGTON, Mass. , Feb. 12, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2019 after market close on Monday, February 24, 2020. |
|
02/04/20
|
Summary ToggleT2 Biosystems Announces Participation at Clinical Conferences in February |
|
Company will highlight need for rapid detection of sepsis-causing pathogens LEXINGTON, Mass. , Feb. 04, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the Company’s participation in two conferences in |